Spero Therapeutics, Inc. Increase (Decrease) in Accounts Payable
Spero Therapeutics, Inc. (SPRO) reported Increase (Decrease) in Accounts Payable of -$538.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-12
- Spero Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$62.00K.
- Spero Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$476.00K.
- Spero Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$702.00K, a 157.73% decline year-over-year.
- Spero Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $615.00K, a 81.88% decline year-over-year.
- Spero Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2025 was -$6.61M, a 211.56% decline from fiscal 2024.
- Spero Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2024 was $5.93M, a 678.98% increase from fiscal 2023.
- Spero Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2023 was $761.00K.
- Spero Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2022 was -$484.00K.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$62.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$538.00K 10-Q · filed 2026-08-12 | -$1.24M derived: sum of 3 quarters · filed 2026-08-12 | -$625.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | -$476.00K 10-Q · filed 2026-05-13 | -$1.18M derived: sum of 2 quarters · filed 2026-05-13 | -$563.00K derived: sum of 3 quarters · filed 2026-05-13 | -$1.55M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | -$702.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$87.00K derived: sum of 2 quarters · filed 2026-03-26 | -$1.07M derived: sum of 3 quarters · filed 2026-08-12 | -$6.61M 10-K · filed 2026-03-26 |
| 2025-09-30 | $615.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$370.00K derived: sum of 2 quarters · filed 2026-08-12 | -$5.91M 10-Q · filed 2025-11-13 | -$4.70M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | -$985.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$6.53M 10-Q · filed 2026-08-12 | -$5.31M derived: sum of 3 quarters · filed 2026-08-12 | -$1.92M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | -$5.54M 10-Q · filed 2026-05-13 | -$4.33M derived: sum of 2 quarters · filed 2026-05-13 | -$931.00K derived: sum of 3 quarters · filed 2026-05-13 | -$1.30M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $4.61M derived: sum of 2 quarters · filed 2026-03-26 | $4.24M derived: sum of 3 quarters · filed 2026-03-26 | $5.93M 10-K · filed 2026-03-26 |
| 2024-09-30 | $3.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $3.02M derived: sum of 2 quarters · filed 2025-11-13 | $4.71M 10-Q · filed 2025-11-13 | $4.99M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | -$370.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $1.32M 10-Q · filed 2025-08-12 | $1.59M derived: sum of 3 quarters · filed 2025-08-12 | $1.39M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $1.69M 10-Q · filed 2025-05-13 | $1.96M derived: sum of 2 quarters · filed 2025-05-13 | $1.76M derived: sum of 3 quarters · filed 2025-05-13 | $2.48M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $275.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $68.00K derived: sum of 2 quarters · filed 2025-03-27 | $795.00K derived: sum of 3 quarters · filed 2025-03-27 | $761.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | -$207.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $520.00K derived: sum of 2 quarters · filed 2024-11-14 | $486.00K 10-Q · filed 2024-11-14 | -$1.48M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $727.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $693.00K 10-Q · filed 2024-08-05 | -$1.27M derived: sum of 3 quarters · filed 2024-08-05 | -$403.00K derived: sum of 4 quarters · filed 2024-08-05 |
| 2023-03-31 | -$34.00K 10-Q · filed 2024-05-15 | -$2.00M derived: sum of 2 quarters · filed 2024-05-15 | -$1.13M derived: sum of 3 quarters · filed 2024-05-15 | -$4.20M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | -$1.97M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | -$1.10M derived: sum of 2 quarters · filed 2024-03-13 | -$4.16M derived: sum of 3 quarters · filed 2024-03-13 | -$484.00K 10-K · filed 2024-03-13 |
| 2022-09-30 | $871.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$2.20M derived: sum of 2 quarters · filed 2023-11-13 | $1.48M 10-Q · filed 2023-11-13 | -$577.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$3.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $612.00K 10-Q · filed 2023-08-10 | -$1.45M derived: sum of 3 quarters · filed 2023-08-10 | $81.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $3.68M 10-Q · filed 2023-05-11 | $1.62M derived: sum of 2 quarters · filed 2023-05-11 | $3.15M derived: sum of 3 quarters · filed 2023-05-11 | $937.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$2.06M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$531.00K derived: sum of 2 quarters · filed 2023-03-30 | -$2.74M derived: sum of 3 quarters · filed 2023-03-30 | -$53.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | $1.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$682.00K derived: sum of 2 quarters · filed 2022-11-14 | $2.01M 10-Q · filed 2022-11-14 | $688.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$2.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $478.00K 10-Q · filed 2022-08-10 | -$841.00K derived: sum of 3 quarters · filed 2022-08-10 | $70.00K derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $2.69M 10-Q · filed 2022-05-16 | $1.37M derived: sum of 2 quarters · filed 2022-05-16 | $2.28M derived: sum of 3 quarters · filed 2022-05-16 | -$5.11M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | -$1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$408.00K derived: sum of 2 quarters · filed 2022-03-31 | -$7.80M derived: sum of 3 quarters · filed 2022-03-31 | -$2.98M 10-K · filed 2022-03-31 |
| 2020-09-30 | $911.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$6.48M derived: sum of 2 quarters · filed 2021-11-10 | -$1.66M 10-Q · filed 2021-11-10 | -$51.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | -$7.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$2.57M 10-Q · filed 2021-08-05 | -$962.00K derived: sum of 3 quarters · filed 2021-08-05 | $523.00K derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $4.82M 10-Q · filed 2021-05-06 | $6.43M derived: sum of 2 quarters · filed 2021-05-06 | $7.91M derived: sum of 3 quarters · filed 2021-05-06 | $8.40M derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $3.09M derived: sum of 2 quarters · filed 2021-03-11 | $3.57M derived: sum of 3 quarters · filed 2021-03-11 | $564.00K 10-K · filed 2021-03-11 |
| 2019-09-30 | $1.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $1.97M derived: sum of 2 quarters · filed 2020-11-05 | -$1.04M 10-Q · filed 2020-11-05 | $1.13M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $482.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$2.53M 10-Q · filed 2020-08-06 | -$354.00K derived: sum of 3 quarters · filed 2020-08-06 | $305.00K derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | -$3.01M 10-Q · filed 2020-05-08 | -$836.00K derived: sum of 2 quarters · filed 2020-05-08 | -$177.00K derived: sum of 3 quarters · filed 2020-05-08 | -$455.00K derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-12-31 | $2.17M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $2.83M derived: sum of 2 quarters · filed 2020-03-16 | $2.55M derived: sum of 3 quarters · filed 2020-03-16 | $84.00K 10-K · filed 2020-03-16 |
| 2018-09-30 | $659.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $381.00K derived: sum of 2 quarters · filed 2019-11-04 | -$2.09M 10-Q · filed 2019-11-04 | $373.00K derived: sum of 4 quarters · filed 2019-11-04 |
| 2018-06-30 | -$278.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$2.75M 10-Q · filed 2019-08-08 | -$286.00K derived: sum of 3 quarters · filed 2019-08-08 | -$516.00K derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | -$2.47M 10-Q · filed 2019-05-09 | -$8.00K derived: sum of 2 quarters · filed 2019-05-09 | -$238.00K derived: sum of 3 quarters · filed 2019-05-09 | -$38.00K derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | $2.46M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $2.23M derived: sum of 2 quarters · filed 2019-03-14 | $2.43M derived: sum of 3 quarters · filed 2019-03-14 | $2.35M 10-K · filed 2019-03-14 |
| 2017-09-30 | -$230.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$30.00K derived: sum of 2 quarters · filed 2018-11-08 | -$112.00K 10-Q · filed 2018-11-08 | -$77.00K derived: sum of 4 quarters · filed 2019-03-14 |
| 2017-06-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $118.00K 10-Q · filed 2018-08-09 | $153.00K derived: sum of 3 quarters · filed 2019-03-14 | |
| 2017-03-31 | -$82.00K 10-Q · filed 2018-05-10 | -$47.00K derived: sum of 2 quarters · filed 2019-03-14 | ||
| 2016-12-31 | $35.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | -$644.00K 10-K · filed 2019-03-14 | ||
| 2016-09-30 | -$679.00K 10-Q · filed 2017-12-14 | |||
| 2015-12-31 | $671.00K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 |